Tag: LianBio
Ropes & Gray acts for LianBio in heart drug deal with BMS
R&G guides USD350m deal: BMS secures LianBio's heart drug rights for a one-time payment
R&G guides USD350m deal: BMS secures LianBio's heart drug rights for a one-time payment
As mandatory ESG reporting is phased in, green claims may face securities law and cross-border compliance scrutiny. General counsel and environmental lawyers assess the evolving challenges
TSMC general counsel Sylvia Fang charts rise of Taiwan’s semiconductor giant on the world stage and the multijurisdictional challenges
Corporate governance is evolving beyond compliance to encompass accountability, sustainability?and long-term value
Follow us on LinkedIn